Ohio Product Liability Attorney and Pharmaceutical Injury Lawyer reviews fluoroquinolone antibiotic aortic dissection and aortic aneurysm injury risks for plaintiffs nationwide
The FDA recently issued another warning regarding the risks of fluoroquinolone antibiotic injury, noting that use of certain drugs may increase the risk of tears or ruptures of the aorta. Such aortic dissections and aortic aneurysm are rare, but they can lead to death. The new warning comes after the FDA reviewed case reports and published studies that showed that people who had taken flouroqinolones had an increased health risk.
The fluoroquinolone class of drugs is commonly prescribed. Examples are ciprofloxacin, norfloxacin, ofloxacin, delafloxacin, gemifloxacin, levofloxacin and moxifloxacin. The FDA indicates that the injury risk ranges from 9 to 300 per 100,000 people each year.
Joe Lyon is a highly-rated Ohio pharmaceutical attorney and product liability lawyer representing plaintiffs nationwide in a wide variety of wrongful death and injury claims related to fluoroquinolone antibiotic injury and dangerous pharmaceutical products.
An aortic rupture occurs when the wall of the aorta bursts, blood leaks out into the body. Smoking, atherosclerosis, high blood pressure, and various blood vessel diseases and infections can put you at higher risk, as can antibiotic use.
Aortic dissections describe the condition when a collection of blood compresses the inside of the aorta and obstructs the passage of blood, potentially progressing into an aortic rupture. High blood pressure, atherosclerosis, advanced age, blood vessel and connective tissue disorders, and antibiotic use can increase the injury risk.
Fluoroquinolone antibiotics are approved to treat bacterial infections and have been used for more than 30 years. They kill or stop the growth of bacteria that causes illness. The FDA has warned about increased risk of tendinitis and tendon rupture, peripheral neuropathy, significant decreases in blood sugar and certain mental health side effects.
As early as 2008 the FDA noted concerns for this class of antibiotics, and added a “black box” warning to seven fluoroquinolone drug labels and prescribing information, included on the following drugs:
Doctors are urged to stop prescribing fluoroquinolone antibiotics to patients who have an aortic aneurysm or are at risk for an aortic aneurysm. Fluoroquinolones should only be used when no other treatment options are available. Fluoroquinolone treatment should immediately be halted if a patient reports side effects suggestive of aortic aneurysm or aortic dissection.
Patients should inform their doctor before starting any antibiotic prescription if they have a history of aneurysms, blockages or hardening of the arteries, high blood pressure, or genetic conditions such as Marfan syndrome or Ehlers-Danlos syndrome.
If you or a loved one suffered an aortic dissection, aortic aneurysm or another medication-related injury after taking a Fluoroquinolone antibiotic, and have questions about the legal remedies available to improve quality of life and medical care, contact The Lyon Firm at (800) 513-2403. You will speak directly with Mr. Lyon, and he will help you answer critical questions regarding antibiotics injuries.